Chimeric Switch Receptor: Switching for Improved Adoptive T-Cell Therapy Against Cancers - cytomed
Menu
Home
About
About Us
Our Team
Our Collaboration Partner
Manufacturer
Publications
Briefs
Platform
CAR-γδ T Cell
iPSC-γδ NKT Cell
Pipeline
Investor
Investor Relations
Financial Reports
Banking Services
Contact Us
Shareholder Benefits
Make An Appointment
Chimeric Switch Receptor: Switching for Improved Adoptive T-Cell Therapy Against Cancers
«
Expansion of Gamma Delta T Cells – A Short Review on Bisphosphonate and K562-Based Methods
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
»
